Aurobindo Pharma Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹9,150.35 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.35 per cent from ₹8,853.34 crore. This corresponds to a year-on-year *(YoY) growth of 16.30 per cent.
Operating Profit
Operating Profit stands at ₹1,839.34 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.08 per cent from ₹1,750.35 crore. This corresponds to a year-on-year *(YoY) growth of 14.74 per cent.
PBDT
PBDT stands at ₹2,001.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.15 per cent from ₹1,769.18 crore. This corresponds to a year-on-year *(YoY) growth of 24.15 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,515.09 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.39 per cent from ₹1,290.61 crore. This corresponds to a year-on-year *(YoY) growth of 25.55 per cent.
Net Profit
Net Profit stands at ₹1,032.03 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.07 per cent from ₹920.84 crore. This represents a 25.22 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Aurobindo Pharma Ltd News
Aurobindo Pharma Ltd Earnings
- YOY
- QOQ
Aurobindo Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Aurobindo Pharma Ltd Research Reports
Aurobindo Pharma Ltd Financial Reports
Aurobindo Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aurobindo Pharma | 4.50% | 4.40% | 4.70% | 11.78% | 38.27% | 57.77% |
| Mankind Pharma | 0.33% | -1.43% | -3.65% | -1.23% | 17.10% | 0.10% |
| Laurus Labs | 1.03% | 2.43% | 23.40% | 46.46% | 88.11% | 123.14% |
| Dr Reddy's Labs | -0.26% | 0.18% | -7.70% | -8.42% | -8.07% | -3.87% |
| Biocon | -1.71% | 1.65% | 6.53% | 10.12% | 15.00% | 25.71% |
| Alkem Lab | 0.38% | -0.92% | -0.31% | 0.57% | -2.02% | 16.28% |
| Glenmark Pharma. | -0.52% | 4.98% | 0.96% | -2.69% | 15.79% | 11.67% |
Company Info
Company Information
Vice Chairman & Managing Director : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Chairman & Independent Director : M R Kumar
Non Executive Director : Satakarni Makkapati
Company Sec. & Compli. Officer : B Adi Reddy
Additional Director : Punita Kumar Sinha